"The biggest innovations in the world will come from the intersection of biology & technology." - Steve Jobs
What's powering this intersection of the digital and health world's innovations? A generational shift toward mobile connectivity, technology advancements that allow for big data processing and analytics, and changes to healthcare models, are all part of this massive shift. But how do we get from digital health that focuses on patient engagement through apps and wearables to digital medicine that focuses on the diagnosis and treatment of patients?
Join thought leaders from IBM, iGan Partners (Rowanwood Ventures), LEAGUE, MaRS Innovation and Johnson & Johnson Innovation at JLABS @ Toronto for a panel discussion around the merging of technology and medicine and how we can start making the shift towards the commercialization of these products to begin improving the lives of patients.
Also hear from Johnson & Johnson Innovation's Digital Health Innovation Lead on how they are helping & partnering with startups and making a commitment to digital health innovation globally.
Afterwards, hear pitches from companies within the digital health space, while networking with your peers in the industry at a cocktail reception.
Lori Casselman | Chief Health Officer, League read bio»
Cris De Luca | Digital Health Innovation Leader, Johnson & Johnson Innovation read bio»
Sam Ifergan | Managing Partner, iGan Partners (Rowanwood Ventures) read bio»
Daniel Sinai | Senior Executive, Innovation, IBM Canada read bio»
[Moderator] Fanny Sie | Manager, Technology & Venture Development, MaRS Innovation read bio»
Digital Health Companies Pitching:
- AMA Read More»
- A4i Read More»
- DNAstack Read More»
- HAPPYneuron Read More»
- ITI Communication Read More»
- Maela Read More»
- MHComm Read More»
- Neutun Labs Read More»
- NG Biotech Read More»
5:00 PM | Registration Opens & Networking
5:30 PM | Presentation, Digital Health at JLABS and Johnson & Johnson Innovation
5:45 PM | Panel Discussion
6:45 PM | Digital Health Company Pitches
7:15 PM | Networking
8:00 PM | Program Close
JLABS @ Toronto
661 University Ave, Suite 1300
Lori Casselman | Chief Health Officer, League
Lori has 20 years of experience in the health, wellness and insurance industries, joined League most recently from Sun Life - Canada's leading health insurer - where she held several executive roles in their Group Benefits organization, including running Integrated Health Solutions, Practice Excellence & Innovation and Health & Wellness divisions.
In her latest role Lori was responsible for building and leading Sun Life's innovative health management strategy, with a holistic model focused on physical, mental and financial well-being. Integrated Health Solutions is a core line of business within the Group Benefits unit, supporting a proactive, multi-disciplinary approach to organizational and employee health - from wellness to absence & disability management.
Prior to SunLife, Lori ran a Health & Wellness "startup", Buffett & Associates, one of Canada's first health benefits businesses, that she exited to Sun Life.
Lori has a BA in Kinesiology, a BSc in Nutrition, an MSc in Exercise Physiology, and has completed the Ivey Executive Leadership program. She is on the board of Sanofi-Aventis Healthcare Survey, and Get Active Toronto.
Connect with Lori:
Cris De Luca, MS | Digital Health Innovation Leader, Johnson & Johnson Innovation
Cris is the Digital Health Innovation Leader at Johnson & Johnson Innovation, Boston where he is responsible for external healthcare technology innovation strategy and new ventures. Cris was previously Associate Director at Novartis Institutes for BioMedical Research where he led a Research Informatics organization building social computing and emerging technology programs.
In 2010, Cris Co-Founded the largest startup venture pitch competition in the U.S. called Ultra Light Startups, accelerating hundreds of bootstrapping entrepreneurs in New England, New York, and Silicon Valley. Cris was recognized by the Boston Business Journal as a 40 Under 40 game changer and an honoree of MedTech Boston's 40 Under 40 Healthcare Innovators line-up. He holds a Bachelor of Science in Business Administration from Suffolk University and a Master of Science in Computer Information Systems from Boston University.
Connect with Cris:
Sam Ifergan | Managing Partner, iGan Partners (Rowanwood Ventures)
Sam has over 20 years of entrepreneurial, technology and venture capital experience. As Managing Partner of the iGan Partners team, he is involved in the evaluation, structuring, execution, and monitoring of Rowanwood's investments. Sam has been extensively involved with several companies, often serving as CEO, particularly in the early stages of each company's development. Prior to founding iGan / Rowanwood Ventures, he co-founded several companies including Visualsonics, Tri-Link Technologies and Brighter Minds. Prior to that he was a strategy consultant with Mercer Management Consulting (now Oliver Wyman) where he advised Fortune 500 companies on corporate strategy. Sam has also held general management roles at NCR, where he led the deployment of enterprise-grade information technology systems. Sam holds an MBA from the John Molson School of Business and a Bachelor of Electrical Engineering from McGill University.
Connect with Sam:
Daniel Sinai | Senior Executive, Innovation, IBM Canada
Dan is currently a Senior Executive at IBM Canada where he works with the Canadian start-up community and implements the company’s innovation and incubation initiatives.
Prior to joining IBM, Dan served as Western University's Associate Vice-President (Research). In this capacity, Dan set the strategic direction for, and led, a team of research administration professionals at one of Canada’s leading research-intensive universities.
A graduate of the University of Waterloo, Dan has held various key research administration positions with both the Government of Ontario and the Government of Canada. He also has extensive R&D program and policy experience, and has worked for several high technology companies, including Nortel and EK3 Technologies.
Dan and his family have lived in London, Ontario, Canada for more that 15 years, where he has served on various local Boards of Directors.
Connect with Daniel:
Fanny Sie | Manager, Technology & Venture Development, MaRS Innovation
Fanny Sie's academic studies include Human Biology (HonsBSc) and a Radiation Therapy degree (BSc/M.R.T.(T.)) at the University of Toronto (U of T).
She worked at Princess Margaret Hospital as a radiation research therapist for eight years. In this dual role, she was involved in managing treatment delivery for cancer patients and in researching and developing initiatives for novel optical and imaging devices utilized for treatment target optimization. While enrolled in U of T's Masters of Management of Innovation program, Fanny studied and aided in market-entry strategies of new technologies at various stages of the commercialization pipeline. This education prepared her for the role of clinical applications business analyst for Elekta Oncology Systems in 2009, where she was a liaison between internal developmental engineers, product management, business units and a clinician-based clientele. Her responsibilities included ground-up development, configuration, training and implementing progressive technologies for cancer centers worldwide.
Fanny's current focus is on creating and deploying strategies to accelerate the development and scale of digital health solutions to the market by collaborating with academic institutions, industry partners, investors and government.
Connect with Fanny:
Save This Event
When & Where
JLABS @ Toronto
JLABS, part of Johnson & Johnson Innovation, is a network of life science incubators providing emerging companies many of the advantages of being in a big company, without the capital investment. JLABS offers singular bench tops, modular wet lab units and office space on a short-term basis, allowing companies to pay only for the space they need, with an option to quickly expand when they have the resources to do so. Companies residing at JLABS also have access to core research labs hosting specialized capital equipment and shared administrative areas. JLABS is an open innovation model, and the agreement for space does not grant JLABS or Johnson & Johnson Innovation any stake or rights in the companies, nor will the companies have a guaranteed future affiliation with JLABS. The flagship facility is located in San Diego at Janssen's West Coast Research Center, and JLABS has now two established locations in San Francisco - one through a collaboration with the California Institute for Quantitative Biosciences (QB3) and a second standalone facility - one in Boston through a collaboration with Lab Central, one in Houston through a collaboration with TMC, and one in Toronto through a collaboration with MaRS. For more information please visit jlabs.jnjinnovation.com.